These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported upbeat second-quarter results and raised its full-year guidance. Adjusted earnings came in at $7.45 per share, beating the analyst consensus estimate of $6.21. Revenue rose to $49.83 billion, above the consensus estimate of $48.69 billion. Elevance now expects fis